Search results
Added:
2 weeks ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA…
View more
Added:
2 months ago
Source:
Transcatheter Academy
A large-scale meta-analysis suggests that for patients with severe symptomatic aortic stenosis (AS) at a low- to intermediate-surgical risk, transcatheter aortic valve implantation (TAVI) is associated with a lower risk of all-cause death or any stroke at one year compared with surgical aortic valve replacement (SAVR).¹This study was an individual participant data (IPD) meta-analysis of four…
View more
Added:
2 weeks ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional…
View more
Added:
1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP…
View more
Added:
2 weeks ago
TCT 2025 – Dr Nadira Hamid (Minneapolis Heart Institute, US), interventional echocardiographer sits down with ENCIRCLE's (Edwards Lifesciences) Principal Investigator, Dr David V Daniels (California Pacific Medical Center, US) to have a deep dive into the latest data with SAPIEN M3.The ENCIRCLE trial (NCT04153292) is a prospective, multicentre, single-arm study evaluating the safety and…
View more
Added:
1 year ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more
Added:
2 weeks ago
Source:
Radcliffe Cardiology
Long-term data from the PARTNER 3 trial show no significant differences in key clinical outcomes at 7 years between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This extended follow-up provides crucial insights into the durability and long-term safety of both procedures in this patient…
View more
Added:
6 months ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights…
View more
The FISH&CHIPS Study
Video Series
Added:
1 year ago